Symptomatic gallstone disease is common throughout the world. The prevalence, however, varies. Ultrasonographic and cholecystographic surveys have shown that gallstones are rare in Asian countries (3%-6%),
1,2 whereas they are quite common in the Western world. In the United States, prevalences of 5% to 22% have been reported.
3 In Europe, high prevalences are reported but with regional differences (Germany, 19.7%
4; Norway, 21.9%
5; Sweden, 15%
6). For patients with symptomatic gallstones, the only evidence-based treatment available today is surgery.
7 However, the fact that about one-fifth of the patients undergoing surgery are not relieved of their symptoms emphasizes the importance of careful symptom assessment and establishing the right indications for surgery.
8